In this work, a total of 283 LRRK2 variants were documented in patients with different diseases, and 211 were included and classified as pathogenic, likely pathogenic, or VUS according to the ACMG criteria in patients with PD. The gene discussed is LRRK2; the disease is Parkinson disease.